<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>The skin : a pathway for systemic treatment with patches and lipid-based agent carriers</dc:title>
  <dc:creator>CEVC, G</dc:creator>
  <dc:creator>BLUME, G</dc:creator>
  <dc:creator>SCHÄTZLEIN, A</dc:creator>
  <dc:creator>GEBAUER, D</dc:creator>
  <dc:creator>PAUL, A</dc:creator>
  <dc:contributor>KORTING, Hans C (Editor)</dc:contributor>
  <dc:relation>Advanced drug delivery reviews -- Adv. drug deliv. rev, ISSN 0169-409X, Vol. 18 (3) , pp. 349-378</dc:relation>
  <dc:date>1996</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Elsevier Science</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>138 ref</dc:format>
  <dc:subject xml:lang="fr">Absorption</dc:subject>
  <dc:subject xml:lang="fr">Animal</dc:subject>
  <dc:subject xml:lang="fr">Forme pharmaceutique</dc:subject>
  <dc:subject xml:lang="fr">Formulation</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Liposome</dc:subject>
  <dc:subject xml:lang="fr">Micelle</dc:subject>
  <dc:subject xml:lang="fr">Peau</dc:subject>
  <dc:subject xml:lang="fr">Pharmacocinétique</dc:subject>
  <dc:subject xml:lang="fr">Promoteur absorption</dc:subject>
  <dc:subject xml:lang="fr">Suspension</dc:subject>
  <dc:subject xml:lang="fr">Voie percutanée</dc:subject>
  <dc:subject xml:lang="fr">Transfersome</dc:subject>
  <dc:subject xml:lang="en">Absorption</dc:subject>
  <dc:subject xml:lang="en">Animal</dc:subject>
  <dc:subject xml:lang="en">Dosage form</dc:subject>
  <dc:subject xml:lang="en">Formulation</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Liposome</dc:subject>
  <dc:subject xml:lang="en">Micelle</dc:subject>
  <dc:subject xml:lang="en">Skin</dc:subject>
  <dc:subject xml:lang="en">Pharmacokinetics</dc:subject>
  <dc:subject xml:lang="en">Absorption enhancer</dc:subject>
  <dc:subject xml:lang="en">Suspension</dc:subject>
  <dc:subject xml:lang="en">Percutaneous route</dc:subject>
  <dc:subject xml:lang="es">Absorción</dc:subject>
  <dc:subject xml:lang="es">Animal</dc:subject>
  <dc:subject xml:lang="es">Forma farmacéutica</dc:subject>
  <dc:subject xml:lang="es">Formulación</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Liposoma</dc:subject>
  <dc:subject xml:lang="es">Micela</dc:subject>
  <dc:subject xml:lang="es">Piel</dc:subject>
  <dc:subject xml:lang="es">Farmacocinética</dc:subject>
  <dc:subject xml:lang="es">Promotor absorción</dc:subject>
  <dc:subject xml:lang="es">Suspensión</dc:subject>
  <dc:subject xml:lang="es">Vía percutánea</dc:subject>
  <dc:subject>002B02A05: Pharmacocinétique. Pharmacogénétique. Interactions médicament-récepteur / Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 3014097</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>